| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mental Disorders | 6 | 2020 | 18 | 1.960 |
Why?
|
| Humans | 37 | 2024 | 2957 | 1.280 |
Why?
|
| Juvenile Delinquency | 6 | 2011 | 6 | 1.130 |
Why?
|
| Female | 28 | 2024 | 1724 | 1.120 |
Why?
|
| Adolescent | 20 | 2024 | 247 | 1.050 |
Why?
|
| Male | 26 | 2024 | 1860 | 1.050 |
Why?
|
| Aggression | 4 | 2017 | 9 | 1.010 |
Why?
|
| Homeless Youth | 3 | 2020 | 8 | 0.900 |
Why?
|
| Mental Health Services | 3 | 2020 | 10 | 0.900 |
Why?
|
| Primary Health Care | 3 | 2020 | 11 | 0.900 |
Why?
|
| Prisoners | 4 | 2009 | 4 | 0.890 |
Why?
|
| Foster Home Care | 2 | 2017 | 2 | 0.880 |
Why?
|
| Depressive Disorder | 2 | 2019 | 22 | 0.830 |
Why?
|
| Antipsychotic Agents | 3 | 2017 | 7 | 0.710 |
Why?
|
| Young Adult | 9 | 2020 | 187 | 0.650 |
Why?
|
| Cultural Diversity | 3 | 2004 | 5 | 0.640 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2019 | 18 | 0.630 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2019 | 2 | 0.590 |
Why?
|
| Patient Health Questionnaire | 1 | 2019 | 5 | 0.590 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 3 | 0.590 |
Why?
|
| Referral and Consultation | 1 | 2019 | 7 | 0.590 |
Why?
|
| Psychotropic Drugs | 2 | 2017 | 6 | 0.570 |
Why?
|
| Adult | 12 | 2020 | 794 | 0.550 |
Why?
|
| Veterans | 3 | 2019 | 10 | 0.550 |
Why?
|
| Social Behavior | 1 | 2017 | 8 | 0.520 |
Why?
|
| Drug Discovery | 1 | 2017 | 3 | 0.510 |
Why?
|
| Informed Consent | 1 | 2017 | 10 | 0.510 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 10 | 0.510 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 27 | 0.500 |
Why?
|
| Social Media | 2 | 2017 | 17 | 0.480 |
Why?
|
| Violence | 3 | 2024 | 6 | 0.470 |
Why?
|
| Students, Medical | 3 | 2004 | 16 | 0.460 |
Why?
|
| Natural Language Processing | 3 | 2020 | 3 | 0.460 |
Why?
|
| Adolescent Behavior | 2 | 2012 | 6 | 0.450 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 6 | 0.430 |
Why?
|
| Risk-Taking | 1 | 2014 | 4 | 0.430 |
Why?
|
| Antisocial Personality Disorder | 2 | 2011 | 3 | 0.420 |
Why?
|
| United States | 7 | 2024 | 243 | 0.420 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 17 | 0.410 |
Why?
|
| Rape | 1 | 2013 | 1 | 0.390 |
Why?
|
| Veterans Health | 1 | 2013 | 1 | 0.390 |
Why?
|
| Minority Groups | 2 | 2024 | 11 | 0.380 |
Why?
|
| Substance-Related Disorders | 3 | 2024 | 25 | 0.370 |
Why?
|
| Group Processes | 1 | 2012 | 1 | 0.370 |
Why?
|
| Social Support | 1 | 2012 | 7 | 0.370 |
Why?
|
| Adolescent Development | 1 | 2012 | 3 | 0.370 |
Why?
|
| Family Therapy | 1 | 2011 | 1 | 0.360 |
Why?
|
| Systems Theory | 1 | 2011 | 1 | 0.360 |
Why?
|
| Urban Population | 1 | 2011 | 23 | 0.350 |
Why?
|
| Middle Aged | 8 | 2019 | 792 | 0.350 |
Why?
|
| Alcoholism | 3 | 2020 | 7 | 0.340 |
Why?
|
| Electronic Health Records | 3 | 2020 | 6 | 0.340 |
Why?
|
| Central Nervous System Stimulants | 2 | 2016 | 19 | 0.340 |
Why?
|
| Valproic Acid | 1 | 2009 | 1 | 0.310 |
Why?
|
| Machine Learning | 2 | 2020 | 7 | 0.300 |
Why?
|
| Curriculum | 3 | 2004 | 38 | 0.300 |
Why?
|
| Crime | 1 | 2009 | 1 | 0.290 |
Why?
|
| Criminal Psychology | 1 | 2009 | 1 | 0.290 |
Why?
|
| Temperament | 1 | 2009 | 1 | 0.290 |
Why?
|
| Criminals | 1 | 2009 | 1 | 0.290 |
Why?
|
| Impulsive Behavior | 1 | 2009 | 5 | 0.290 |
Why?
|
| Child | 5 | 2020 | 197 | 0.280 |
Why?
|
| Military Personnel | 2 | 2019 | 8 | 0.280 |
Why?
|
| Chicago | 3 | 2019 | 160 | 0.280 |
Why?
|
| Mobile Applications | 2 | 2019 | 9 | 0.280 |
Why?
|
| Character | 1 | 2008 | 1 | 0.280 |
Why?
|
| Arousal | 1 | 2008 | 6 | 0.280 |
Why?
|
| Stress, Psychological | 1 | 2008 | 24 | 0.270 |
Why?
|
| Teaching | 2 | 2004 | 14 | 0.270 |
Why?
|
| Delirium | 1 | 2007 | 2 | 0.260 |
Why?
|
| Treatment Outcome | 3 | 2017 | 186 | 0.250 |
Why?
|
| Algorithms | 1 | 2007 | 52 | 0.250 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2006 | 1 | 0.250 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2006 | 1 | 0.250 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 2 | 0.250 |
Why?
|
| Self Disclosure | 1 | 2006 | 1 | 0.250 |
Why?
|
| Psychopathology | 1 | 2006 | 3 | 0.250 |
Why?
|
| Dementia | 1 | 2006 | 73 | 0.240 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2006 | 1 | 0.240 |
Why?
|
| Transaminases | 1 | 2005 | 1 | 0.230 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 2 | 0.230 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2005 | 2 | 0.230 |
Why?
|
| Simvastatin | 1 | 2005 | 5 | 0.230 |
Why?
|
| Triazoles | 1 | 2005 | 3 | 0.230 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 2 | 0.230 |
Why?
|
| Rhabdomyolysis | 1 | 2005 | 3 | 0.230 |
Why?
|
| Prejudice | 2 | 2003 | 3 | 0.230 |
Why?
|
| Mental Health | 2 | 2017 | 8 | 0.220 |
Why?
|
| Brain | 1 | 2006 | 202 | 0.220 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2004 | 11 | 0.210 |
Why?
|
| Education, Medical | 1 | 2004 | 21 | 0.210 |
Why?
|
| Sex Factors | 4 | 2020 | 72 | 0.210 |
Why?
|
| Students | 1 | 2024 | 7 | 0.200 |
Why?
|
| Telemedicine | 1 | 2024 | 14 | 0.200 |
Why?
|
| Education, Medical, Graduate | 1 | 2003 | 13 | 0.200 |
Why?
|
| Ambulatory Care Facilities | 2 | 2020 | 3 | 0.200 |
Why?
|
| Inpatients | 2 | 2020 | 3 | 0.190 |
Why?
|
| Refugees | 2 | 2014 | 2 | 0.180 |
Why?
|
| Communication | 1 | 2001 | 13 | 0.170 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 105 | 0.160 |
Why?
|
| Pediatrics | 1 | 2020 | 8 | 0.160 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 2 | 0.160 |
Why?
|
| Mass Screening | 1 | 2020 | 12 | 0.160 |
Why?
|
| Housing | 1 | 2020 | 2 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2019 | 1 | 0.150 |
Why?
|
| Supervised Machine Learning | 1 | 2019 | 1 | 0.150 |
Why?
|
| Psychology, Adolescent | 2 | 2011 | 2 | 0.150 |
Why?
|
| Physician-Patient Relations | 2 | 2013 | 5 | 0.150 |
Why?
|
| Trauma Centers | 1 | 2019 | 2 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 7 | 0.150 |
Why?
|
| Personality Inventory | 2 | 2009 | 7 | 0.140 |
Why?
|
| Conduct Disorder | 2 | 2009 | 2 | 0.140 |
Why?
|
| California | 2 | 2009 | 13 | 0.140 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 1 | 0.130 |
Why?
|
| Social Adjustment | 1 | 2017 | 5 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 44 | 0.130 |
Why?
|
| Animals | 2 | 2017 | 1050 | 0.120 |
Why?
|
| Child Psychiatry | 1 | 2016 | 1 | 0.120 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 142 | 0.120 |
Why?
|
| Neuropsychological Tests | 2 | 2006 | 238 | 0.120 |
Why?
|
| Interpersonal Relations | 2 | 2012 | 12 | 0.110 |
Why?
|
| Escape Reaction | 1 | 2014 | 1 | 0.100 |
Why?
|
| Minors | 1 | 2014 | 1 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2019 | 233 | 0.100 |
Why?
|
| United Kingdom | 2 | 2004 | 7 | 0.100 |
Why?
|
| Aged | 3 | 2017 | 956 | 0.100 |
Why?
|
| Physician's Role | 1 | 2013 | 1 | 0.100 |
Why?
|
| Psychology, Military | 1 | 2013 | 1 | 0.100 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 2 | 0.100 |
Why?
|
| Medical History Taking | 1 | 2013 | 4 | 0.100 |
Why?
|
| Physical Examination | 1 | 2013 | 11 | 0.100 |
Why?
|
| Mental Status Schedule | 1 | 2013 | 29 | 0.100 |
Why?
|
| Acrosome | 1 | 1992 | 1 | 0.090 |
Why?
|
| Spermatocytes | 1 | 1992 | 1 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 2 | 0.090 |
Why?
|
| Mass Behavior | 1 | 2012 | 1 | 0.090 |
Why?
|
| Social Change | 1 | 2012 | 1 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2012 | 51 | 0.090 |
Why?
|
| Psychology | 1 | 2011 | 3 | 0.080 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 6 | 0.080 |
Why?
|
| Drug Resistance | 1 | 2009 | 1 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 17 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2019 | 19 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 50 | 0.070 |
Why?
|
| Interview, Psychological | 1 | 2009 | 4 | 0.070 |
Why?
|
| Child, Abandoned | 1 | 2009 | 1 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2019 | 21 | 0.070 |
Why?
|
| Free Association | 1 | 2008 | 1 | 0.070 |
Why?
|
| Heart Rate | 1 | 2008 | 16 | 0.070 |
Why?
|
| Haloperidol | 1 | 2007 | 1 | 0.060 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2007 | 1 | 0.060 |
Why?
|
| Risperidone | 1 | 2007 | 1 | 0.060 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2007 | 1 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 3 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2007 | 8 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 8 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 85 | 0.060 |
Why?
|
| Electroshock | 1 | 2006 | 1 | 0.060 |
Why?
|
| Tauopathies | 1 | 2006 | 1 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 3 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 3 | 0.060 |
Why?
|
| Atrophy | 1 | 2006 | 10 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 5 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 9 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 29 | 0.060 |
Why?
|
| Comorbidity | 1 | 2006 | 49 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 33 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 28 | 0.060 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 1 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 77 | 0.060 |
Why?
|
| Disease Progression | 1 | 2006 | 99 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 85 | 0.060 |
Why?
|
| Psychopharmacology | 1 | 2006 | 2 | 0.060 |
Why?
|
| Adolescent Psychiatry | 1 | 2006 | 1 | 0.060 |
Why?
|
| Prognosis | 1 | 2006 | 39 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 1 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 7 | 0.060 |
Why?
|
| Piperazines | 1 | 2005 | 6 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2005 | 13 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 97 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 13 | 0.050 |
Why?
|
| Illinois | 1 | 2004 | 22 | 0.050 |
Why?
|
| Crime Victims | 1 | 2024 | 3 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2003 | 14 | 0.050 |
Why?
|
| Austria | 2 | 2014 | 2 | 0.050 |
Why?
|
| State Medicine | 1 | 2001 | 2 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2020 | 1 | 0.040 |
Why?
|
| Marijuana Abuse | 1 | 2020 | 2 | 0.040 |
Why?
|
| Medical Records | 1 | 2020 | 1 | 0.040 |
Why?
|
| Unified Medical Language System | 1 | 2020 | 1 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 27 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 13 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 60 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 19 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 89 | 0.040 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2019 | 8 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 8 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 62 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 4 | 0.040 |
Why?
|
| Psychotherapy, Group | 1 | 2019 | 8 | 0.040 |
Why?
|
| Health Promotion | 1 | 2019 | 25 | 0.040 |
Why?
|
| Text Messaging | 1 | 2019 | 6 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 14 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 83 | 0.040 |
Why?
|
| Psychometrics | 1 | 2019 | 27 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 47 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 74 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 20 | 0.040 |
Why?
|
| Risk Factors | 2 | 2011 | 275 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 12 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2017 | 167 | 0.030 |
Why?
|
| Methylphenidate | 1 | 2016 | 2 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 5 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 7 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 567 | 0.030 |
Why?
|
| Family Relations | 1 | 2014 | 1 | 0.030 |
Why?
|
| Warfare | 1 | 2014 | 1 | 0.030 |
Why?
|
| Resilience, Psychological | 1 | 2014 | 2 | 0.030 |
Why?
|
| Africa | 1 | 2014 | 4 | 0.030 |
Why?
|
| Life Change Events | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1992 | 1 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1992 | 1 | 0.020 |
Why?
|
| Spermatids | 1 | 1992 | 1 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 4 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1992 | 2 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 5 | 0.020 |
Why?
|
| Antibodies | 1 | 1992 | 16 | 0.020 |
Why?
|
| Turkey | 1 | 2011 | 1 | 0.020 |
Why?
|
| Yugoslavia | 1 | 2011 | 1 | 0.020 |
Why?
|
| Mice | 1 | 1992 | 343 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2011 | 3 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 39 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 34 | 0.020 |
Why?
|
| Motivation | 1 | 2011 | 20 | 0.020 |
Why?
|
| Child Welfare | 1 | 2009 | 2 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2009 | 119 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2006 | 1 | 0.020 |
Why?
|
| Parenting | 1 | 2006 | 3 | 0.020 |
Why?
|